Drug Target Discovery Is Focus for ID Structural Genomics Centers

@inproceedings{Otrompke2014DrugTD,
  title={Drug Target Discovery Is Focus for ID Structural Genomics Centers},
  author={John J Otrompke},
  year={2014}
}
The Seattle Structural Genomics Center for Infectious Disease (SSGCID) and the Chicago-based Center for Structural Genomics of Infectious Diseases (CSGID) recently received renewal grants, worth $25 million over five years and dedicated to solving three-dimensional (3-D) structures of proteins or other macromolecules from microorganisms of biodefense and emerging infectious disease (ID) importance. Solving such structures is part of a broader effort toward discovery and early-stage drug… CONTINUE READING

Topics from this paper.